Movement Alert|Philip Morris Rises 3.06% in Regular Trading, Zyn Ultra US Launch Seen as Potential Catalyst

Market Focus06-06

On June 5, Philip Morris International rose 3.06% in regular trading, trading at $180.24/share, with trading volume of $355 million.

On the news front, Morgan Stanley identified the company's US launch of Zyn Ultra nicotine pouches as a potential stock catalyst. Philip Morris announced at an investor conference that it is rolling out Zyn Ultra in the US this month in 9- and 11-milligram strengths across a range of flavors similar to its original Zyn offerings, following the FDA's new enforcement guidance for nicotine pouches and e-vapor products. Morgan Stanley also highlighted that the company's heat-not-burn category in Japan has been roughly matching expectations, with IQOS maintaining market share stability even after a significant excise tax-driven price increase on April 1. The firm projected above-consensus earnings for the company.

Within the Tobacco sector, the broader group showed strength. Among individual stocks, British American Tobacco up 4.28%, Altria up 3.6%, Universal up 2.14%, Turning Point up 0.07%, RLX Technology down 0.5%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment